Facebook
Twitter
Telegram
Report an ErrorBiocept Balance Sheet 2011-2024 | BIOC
Annual Balance Sheet Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-11.2 M | -27 M | -3.6 M | -6.76 M | -1.8 M | 581 K | -1.55 M | -4.59 M | -485 K | 7.11 M | 22.2 M | 13.2 M |
Long Term Debt |
1.2 M | 1.43 M | 9.81 M | - | - | - | 1.12 M | 2.64 M | 4.75 M | - | 745 K | 1.58 M |
Long Term Debt Current |
518 K | 426 K | - | 842 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 11.3 M | 973 K | 1.1 M | 1.42 M | 2.53 M | 3.55 M | 5.38 M | 462 K | 1.26 M | 1.93 M |
Total Current Liabilities |
5.51 M | 11.8 M | 12.5 M | 5.56 M | 4.61 M | 4.66 M | 4.39 M | 3.34 M | 1.43 M | - | - | - |
Total Liabilities |
22 M | 22.9 M | 23.8 M | 6.53 M | 5.71 M | 6.08 M | 6.92 M | 6.89 M | 6.81 M | 13.8 M | 28.9 M | 17.4 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-298 M | -266 M | - | -246 M | -220 M | -195 M | -174 M | -155 M | -138 M | -122 M | -113 M | -101 M |
Total Assets |
30.9 M | 60.4 M | 47.5 M | 17.7 M | 8.75 M | 7.38 M | 7.58 M | 10.6 M | 6.59 M | 1.33 M | 1.47 M | 2.06 M |
Cash and Cash Equivalents |
12.9 M | 28.9 M | 14.4 M | 9.3 M | 3.42 M | 2.15 M | 4.61 M | 8.82 M | 5.36 M | 69.2 K | - | - |
Book Value |
8.86 M | 37.5 M | 23.7 M | 11.2 M | 3.04 M | 1.3 M | 659 K | 3.69 M | -221 K | -12.5 M | -27.4 M | -15.4 M |
Total Shareholders Equity |
8.86 M | 37.5 M | 23.7 M | 11.2 M | 3.04 M | 1.3 M | 659 K | 3.69 M | -221 K | -12.5 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Biocept
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
836 K | 1.01 M | 1.2 M | 1.01 M | 957 K | 1.22 M | 1.43 M | 1.63 M | 1.63 M | 1.82 M | 1.46 M | 1.46 M | 1.46 M | 1.46 M | 973 K | 973 K | 973 K | 973 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 973 K | 1.03 M | 983 K | 1.45 M | 1.1 M | 1.17 M | 1.26 M | 1.36 M | 1.42 M | 1.26 M | 1.56 M | 2.06 M | 2.53 M | 2.79 M | 3.13 M | 3.13 M | 3.55 M | 3.88 M | 4.23 M | 5.08 M | 5.35 M | 5.31 M | 5.18 M | 473 K | 462 K | 167 K | 509 K | 1.25 M | - | - | - | - | - | - | - | - |
Total Liabilities |
21.8 M | 20.6 M | 22 M | 23.6 M | 25.7 M | 24.9 M | 22.9 M | 22.9 M | 21.3 M | 23.5 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 6.53 M | 6.53 M | 6.53 M | 6.53 M | 5.71 M | 5.71 M | 5.71 M | 5.71 M | 6.08 M | 6.08 M | 6.08 M | 6.08 M | 6.92 M | 6.92 M | 6.92 M | 6.92 M | 6.89 M | 6.89 M | 6.89 M | 6.89 M | 6.79 M | 6.79 M | 6.79 M | 6.79 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-309 M | -306 M | -298 M | -280 M | -274 M | -269 M | -266 M | -263 M | -263 M | -261 M | -264 M | -264 M | -264 M | -264 M | -246 M | -246 M | -246 M | -246 M | -220 M | -220 M | -220 M | -220 M | -195 M | -195 M | -195 M | -195 M | -174 M | -174 M | -174 M | -174 M | -155 M | -155 M | -155 M | -155 M | -138 M | -138 M | -138 M | -138 M | -122 M | -122 M | -122 M | -122 M | - | - | - | - | - | - | - | - |
Total Assets |
22.1 M | 23 M | 30.9 M | 51.1 M | 58.1 M | 61.9 M | 60.4 M | 61.9 M | 50.6 M | 50.3 M | 47.5 M | 47.5 M | 47.5 M | 47.5 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 8.75 M | 8.75 M | 8.75 M | 8.75 M | 7.38 M | 7.38 M | 7.38 M | 7.38 M | 7.58 M | 7.58 M | 7.58 M | 7.58 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 6.57 M | 6.57 M | 6.57 M | 6.57 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
6.63 M | 6.77 M | 12.9 M | 18 M | 22.9 M | 27.6 M | 28.9 M | 27.7 M | 19.5 M | 14.2 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 3.42 M | 3.42 M | 3.42 M | 3.42 M | 2.15 M | 2.15 M | 2.15 M | 2.15 M | 4.61 M | 679 K | 3.75 M | 4.57 M | 8.82 M | 12.5 M | 8.82 M | 8.82 M | 5.36 M | 5.36 M | 5.36 M | 5.36 M | 69.2 K | 69.2 K | 69.2 K | 69.2 K | 185 K | - | - | - | - | - | - | - |
Book Value |
290 K | 2.43 M | 8.86 M | 27.5 M | 32.5 M | 37 M | 37.5 M | 39 M | 29.4 M | 26.8 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 3.04 M | 3.04 M | 3.04 M | 3.04 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 659 K | 659 K | 659 K | 659 K | 3.69 M | 3.69 M | 3.69 M | 3.69 M | -221 K | -221 K | -221 K | -221 K | -12.5 M | -12.5 M | -12.5 M | -12.5 M | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
290 K | 2.43 M | 8.86 M | 27.5 M | 27.7 M | 37 M | 37.5 M | 39 M | 29.4 M | 26.8 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 3.04 M | 3.04 M | 3.04 M | 3.04 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 659 K | 659 K | 659 K | 659 K | 3.69 M | 3.69 M | 3.69 M | 3.69 M | -221 K | -221 K | -221 K | -221 K | -12.5 M | -12.5 M | -12.5 M | -12.5 M | -27.4 M | - | - | - | - | - | - | - |
All numbers in USD currency